Luoxin Pharmaceuticals Group Stock Co Ltd (002793) — Capital Reinvestment Ratio
Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥90.75 Million) in capital expenditures (CN¥7.34 Million). See cash generation quality of Luoxin Pharmaceuticals Group Stock Co Lt to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Luoxin Pharmaceuticals Group Stock Co Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Luoxin Pharmaceuticals Group Stock Co Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2025. For live market cap and broader valuation context, see how much is Luoxin Pharmaceuticals Group Stock Co Lt worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.13x | CN¥253.07 Million | CN¥32.18 Million | ▼ -71.0% |
| 2023 | 0.44x | CN¥552.79 Million | CN¥242.39 Million | ▼ -82.9% |
| 2021 | 2.56x | CN¥120.63 Million | CN¥309.03 Million | ▼ -48.7% |
| 2019 | 4.99x | CN¥116.33 Million | CN¥580.58 Million | ▲ +203.1% |
| 2018 | 1.65x | CN¥114.12 Million | CN¥187.87 Million | ▲ +4.5% |
| 2017 | 1.57x | CN¥102.27 Million | CN¥161.07 Million | ▲ +61.3% |
| 2016 | 0.98x | CN¥72.74 Million | CN¥71.01 Million | ▲ +36.0% |
| 2015 | 0.72x | CN¥58.12 Million | CN¥41.73 Million | ▼ -46.0% |
| 2014 | 1.33x | CN¥41.83 Million | CN¥55.58 Million | ▲ +341.6% |
| 2013 | 0.30x | CN¥64.75 Million | CN¥19.48 Million | ▼ -87.6% |
| 2012 | 2.43x | CN¥33.31 Million | CN¥80.96 Million | ▲ +385.1% |
| 2011 | 0.50x | CN¥46.53 Million | CN¥23.31 Million | — |